We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRLN icon
3376
State Street Blackstone Senior Loan ETF
SRLN
$5.3B
$395K ﹤0.01%
+8,455
New +$395K
EXCU
3377
DELISTED
Exelon Corporation
EXCU
$395K ﹤0.01%
8,000
ARLZ
3378
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$393K ﹤0.01%
+119,113
New +$450K
CNCE
3379
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$392K ﹤0.01%
34,894
+13,839
+66% +$176K
MCHB
3380
Mechanics Bancorp
MCHB
$3.65B
$391K ﹤0.01%
19,605
-77,647
-80% -$1.62M
OTIC
3381
DELISTED
Otonomy, Inc.
OTIC
$389K ﹤0.01%
24,528
+7,259
+42% +$108K
PTVCB
3382
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$388K ﹤0.01%
15,735
+5,879
+60% +$143K
ENOC
3383
DELISTED
EnerNOC, Inc.
ENOC
$388K ﹤0.01%
61,279
-84,133
-58% -$583K
EVC icon
3384
Entravision Communication
EVC
$1.02B
$387K ﹤0.01%
57,561
+25,314
+79% +$181K
XBIT icon
3385
XBiotech
XBIT
$68.6M
$385K ﹤0.01%
+18,413
New +$266K
CCRN
3386
DELISTED
Cross Country Healthcare
CCRN
$384K ﹤0.01%
27,628
-8,570
-24% -$114K
SEAC
3387
DELISTED
Seachange International Inc
SEAC
$383K ﹤0.01%
6,011
+5,510
+1,100% +$406K
CEL
3388
DELISTED
Cellcom Israel, Ltd.
CEL
$383K ﹤0.01%
58,405
-1,253
-2% -$9.28K
GLOP
3389
DELISTED
GASLOG PARTNERS LP
GLOP
$382K ﹤0.01%
20,121
-3,510
-15% -$65.4K
IOVA icon
3390
Iovance Biotherapeutics
IOVA
$2.04B
$381K ﹤0.01%
47,020
+4,833
+11% +$30.4K
PSEC icon
3391
Prospect Capital
PSEC
$1.08B
$381K ﹤0.01%
48,793
-30,938
-39% -$233K
XTLY
3392
DELISTED
Xactly Corporation
XTLY
$381K ﹤0.01%
+29,763
New +$277K
DJCO icon
3393
Daily Journal
DJCO
$826M
$380K ﹤0.01%
+1,600
New +$325K
AAXJ icon
3394
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.51B
$379K ﹤0.01%
6,935
-72,455
-91% -$3.88M
RRMS
3395
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
$379K ﹤0.01%
14,344
-575,347
-98% -$11.7M
PRDO icon
3396
Perdoceo Education
PRDO
$2.17B
$377K ﹤0.01%
63,168
+44,942
+247% +$244K
ATCO
3397
DELISTED
Atlas Corp.
ATCO
$374K ﹤0.01%
26,807
+4,054
+18% +$65K
PHIIK
3398
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$374K ﹤0.01%
20,951
+4,095
+24% +$77.8K
NOVT icon
3399
Novanta
NOVT
$4.91B
$373K ﹤0.01%
+24,590
New +$378K
SHLD
3400
DELISTED
Sears Holding Corporation
SHLD
$371K ﹤0.01%
27,238
-19,056
-41% -$269K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.